• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    More On RDHL

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    RedHill Biopharma Ltd. (RDHL)

    -NasdaqCM
    17.52 Down 0.29(1.63%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:17.81
    Open:17.93
    Bid:N/A
    Ask:20.16 x 300
    1y Target Est:31.00
    Beta:-0.43
    Next Earnings Date:N/A
    Day's Range:17.27 - 17.93
    52wk Range:6.89 - 22.22
    Volume:10,291
    Avg Vol (3m):69,481
    Market Cap:164.11M
    P/E (ttm):N/A
    EPS (ttm):-2.17
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RDHL

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16,682.63
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.91
    Quarterly EPS Est (Jun-15) :-0.46
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RedHill Biopharma Ltd., a biopharmaceutical company, focuses on the development and acquisition of late clinical-stage, proprietary, and orally-administered drugs for the treatment of inflammatory and gastrointestinal diseases, including gastroint... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback